![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2007, American Society of Plant Biologists Two Distinct Forms of M-Locus Protein Kinase Localize to the Plasma Membrane and Interact Directly with S-Locus Receptor Kinase to Transduce Self-Incompatibility Signaling in Brassica rapa[W] aGraduate School of Biological Sciences, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma 630-0192, Japan bGraduate School of Life Sciences, Tohoku University, Aoba 980-8577, Japan 1These authors contributed equally to this work. 2Current address: Department of Biology, Duke University, Durham, NC 27708-1000. 3Current address: Yokogawa Analytical Systems, 9-1 Takakura, Hachioji 192-0033, Japan. 4Address correspondence to takayama/at/bs.naist.jp. Received December 25, 2006; Revised November 13, 2007; Accepted November 15, 2007. This article has been cited by other articles in PMC.Abstract Many flowering plants possess systems of self-incompatibility (SI) to prevent inbreeding. In Brassica, SI recognition is controlled by the multiallelic gene complex (S-haplotypes) at the S-locus, which encodes both the male determinant S-locus protein 11 (SP11/SCR) and the female determinant S-receptor kinase (SRK). Upon self-pollination, the S-haplotype–specific interaction between the pollen-borne SP11 and the cognate stigmatic SRK receptor induces SI signaling in the stigmatic papilla cell and results in rejection of the self-pollen. Our genetic analysis of a self-compatible mutant revealed the involvement of a cytoplasmic protein kinase, M-locus protein kinase (MLPK), in the SI signaling, but its exact physiological function remains unknown. In this study, we identified two different MLPK transcripts, MLPKf1 and MLPKf2, which are produced using alternative transcriptional initiation sites and encode two isoforms that differ only at the N termini. While MLPKf1 and MLPKf2 exhibited distinct expression profiles, both were expressed in papilla cells. MLPKf1 localizes to the plasma membrane through its N-terminal myristoylation motif, while MLPKf2 localizes to the plasma membrane through its N-terminal hydrophobic region. Although both MLPKf1 and MLPKf2 could independently complement the mlpk/mlpk mutation, their mutant forms that lack the plasma membrane localization motifs failed to complement the mutation. Furthermore, a bimolecular fluorescence complementation assay revealed direct interactions between SRK and the MLPK isoforms in planta. These results suggest that MLPK isoforms localize to the papilla cell membrane and interact directly with SRK to transduce SI signaling. INTRODUCTION Self-incompatibility (SI) is a genetic system present in flowering plants that promotes outbreeding by rejecting self-pollen (de Nettancourt, 2001; Takayama and Isogai, 2005). SI is based on the discrimination of self and non-self between pollen and pistil, followed by selective inhibition of self-pollen germination and/or growth. In Brassica, SI recognition is controlled by a multiallelic gene complex (termed the S-haplotype; S1, S2, —, Sn) at a single locus, termed the S-locus. More than 100 S-haplotypes are thought to be present in certain Brassica species (Nou et al., 1993). Genomic analyses of the Brassica S-locus revealed the presence of three multiallelic genes: S-receptor kinase (SRK) (Stein et al., 1991), S-locus protein 11 (SP11; also called S-locus Cys rich [SCR]) (Schopfer et al., 1999; Suzuki et al., 1999), and S-locus glycoprotein (SLG) (Nasrallah et al., 1987; Takayama et al., 1987). SRK encodes a membrane-spanning Ser/Thr receptor kinase that localizes to the papilla cell membrane and functions as the sole determinant of the SI phenotype of the stigma (Takasaki et al., 2000). SP11 encodes a small Cys-rich protein that localizes to the pollen coat and functions as the sole determinant of the SI phenotype of the pollen (Schopfer et al., 1999; Takayama et al., 2000; Shiba et al., 2001). SLG encodes a secreted glycoprotein that shares significant sequence similarity with the extracellular domain of SRK and is abundant in the papilla cell wall. Transformation experiments suggested that SLG is not involved directly in SI phenotype determination, and its physiological role remains controversial (Takasaki et al., 2000; Silva et al., 2001). Biochemical studies have clearly shown that SP11 is a ligand for SRK, and the specificity of the SI response can now be explained by the S-haplotype–specific interactions between the SP11 ligand and the SRK receptor (Kachroo et al., 2001; Takayama et al., 2001). During a self-pollination event, the pollen-borne SP11 ligand binds specifically to the extracellular domain of its cognate self SRK and activates its kinase domain (Cabrillac et al., 2001; Takayama et al., 2001; Shimosato et al., 2007). This activation presumably triggers a signaling cascade that results in the inhibition of pollen hydration, germination, and the penetration of the pollen tube into the papilla cell wall. However, our understanding of the signal transduction pathway downstream of SRK is limited. Arm repeat containing1 (ARC1), a stigmatic U-box protein with E3 ubiquitin ligase activity, is a potent positive mediator of this signal transduction pathway (Stone et al., 2003). ARC1 interacts with the kinase domain of SRK in a phosphorylation-dependent manner via a C-terminal arm repeat domain, and antisense suppression of ARC1 resulted in a partial breakdown in the SI response (Gu et al., 1998; Stone et al., 1999). In one model, ARC1 is activated by SRK and then promotes the ubiquitination and proteasomal degradation of unknown compatibility factors in the pistil, which in turn results in pollen rejection. However, most components of this model require experimental validation. We have recently identified another positive mediator of SI signaling by genetically analyzing a spontaneous self-compatible mutant of Brassica rapa var Yellow Sarson (Murase et al., 2004). Yellow Sarson has a recessive mutation of the modifier (m) gene, which completely eliminates the SI response in the stigma. Positional cloning of the M gene revealed that it encodes a cytoplasmic Ser/Thr protein kinase, designated M-locus protein kinase (MLPK). The mutant form of mlpk has a missense mutation in the conserved kinase subdomain VIa that results in the loss of kinase activity. MLPK belongs to a subfamily of the receptor-like cytoplasmic kinase (RLCK) family, the members of which share a common monophyletic origin with receptor-like kinases but have no apparent signal sequences or transmembrane domains (Shiu and Bleecker, 2001). Although the genome of Arabidopsis thaliana contains as many as 150 RLCKs, little is known about the function of any RLCK. MLPK is the sole example suggested to mediate the signaling of receptor-like kinases, but the exact function of MLPK, especially the physiological relationship between MLPK and SRK, has not yet been elucidated. Here, we analyzed MLPK expression in detail and found two different transcripts, which we call MLPKf1 and MLPKf2. MLPKf1 is the transcript previously reported (Murase et al., 2004), and MLPKf2 is a newly identified transcript produced by an alternative transcription initiation site present in the third intron of the MLPKf1 gene. The use of two alternative transcription initiation sites generates two MLPK isoforms that differ only at their N termini. While MLPKf2 is transcribed and predominantly expressed in the stigma, MLPKf1 is divergently transcribed in the stigma, leaf, and stem. Although both MLPK isoforms localized to the plasma membrane, the localization of MLPKf1 is myristoylation dependent, while that of MLPKf2 is dependent upon its specific N-terminal hydrophobic region. Transient expression of MLPKf2, as well as that of MLPKf1, complemented the mlpk/mlpk mutation and restored the SI phenotype in mutated papilla cells, but the MLPK mutants that lack the plasma membrane localization motifs failed to complement the mlpk/mlpk mutation. Furthermore, a bimolecular fluorescence complementation (BiFC) assay in plant protoplasts revealed a direct interaction between SRK and the MLPK isoforms. These results suggested that MLPK isoforms localize to the papilla cell membrane and interact directly with SRK to transduce SI signaling. RESULTS Identification of Alternative Transcriptional Isoforms of MLPK In our previous work (Murase et al., 2004), we obtained the MLPK cDNA sequence, which covers the entire coding region, by RT-PCR using primers based on the cDNA sequence of APK1b, a putative Arabidopsis ortholog of MLPK (Hirayama and Oka, 1992). To further characterize the MLPK transcript, we performed 5′ rapid amplification of the cDNA ends (5′ RACE) with stigmatic cDNA. The 5′ RACE analysis revealed two isoforms of the MLPK gene product expressed in the stigma (Figure 1
In the 5′ RACE analysis using stigmatic cDNA, MLPKf2 was the major amplification product (MLPKf2, 26 clones; MLPKf1, 2 clones). To confirm that MLPKf2 was the major transcript expressed in the stigma, we screened stigmatic cDNA libraries by plaque or colony hybridization. Of the 10 independent cDNA clones we obtained, four clones contained the short fragments common to both isoforms, but the other six contained the longer fragments corresponding to MLPKf2 isoform. These data suggest that MLPKf2, rather than MLPKf1, is the major isoform transcribed in the stigma. Tissue-Specific Expression of MLPK Isoforms Previous RNA gel blot analyses suggested that MLPK was predominantly expressed in the stigma but that low expression levels were observed in other tissues (Murase et al., 2004). Although we could not distinguish the two MLPK isoforms by RNA gel blot analysis because they have similar molecular sizes, the 5′ RACE analysis suggested that the major isoform expressed in the stigma was MLPKf2. To confirm this finding, we performed RT-PCR analysis using isoform-specific primers. As expected, strong and specific expression of MLPKf2 was observed in the stigma (Figure 2A
To further confirm that these isoforms are expressed in the papilla cell of stigma, where the SI recognition event occurs, we conducted an in situ hybridization analysis (Figure 2C APK1b is thought to be an Arabidopsis ortholog of MLPK based on the highest sequence similarity (76% amino acid identity) and genomic synteny between their loci. APK1b has a genomic structure similar to MLPK, and the protein-coding region was predicted to be contained within six exons as MLPKf1 (named APK1bf1). The genomic sequence analysis suggested that the first intron of APK1bf1 contains an MLPK-like potential translation start codon, suggesting the presence of an alternative transcript like MLPKf2 (named APK1bf2). To test this possibility, we performed RT-PCR analysis and found that both isoforms are transcribed (Figure 1C The MLPK Isoforms Localize to the Plasma Membrane by Different Mechanisms Previous biochemical studies using a polyclonal antibody raised against the full-length recombinant MLPKf1 protein have shown that native MLPK protein is localized to the plasma membrane fraction but not to the soluble fraction of stigma extracts (Murase et al., 2004). Considering that two MLPK isoforms are expressed in the stigma, these previous studies suggested that both MLPK isoforms are localized to the plasma membrane. MLPKf1 has a typical plant myristoylation consensus sequence, M-G-X{not EDFKRVWY}-X-X-[STACFGRV]-X{not DE}, at its N terminus (Figure 3A
To test whether the motif in MLPKf1 actually functions as a myristoylation site and that the motif in MLPKf2 does not, in vitro transcription and translation experiments were performed in the presence of 3H-labeled myristic acid (Figure 3C To analyze the relationship between myristoylation and subcellular localization, we transiently expressed green fluorescent protein (GFP) fusions of these MLPK isoforms in protoplasts prepared from tobacco (Nicotiana tabacum) BY-2 cells (Figure 4
The plasma membrane localization of MLPKf2 must depend on its specific N-terminal amino acid sequence. Although no typical membrane localization motif was found in MLPKf2, its hydropathy profile indicates hydrophobicity in the N terminus (Figure 3D Both MLPK Isoforms Complement the Self-Compatible Phenotype of the mlpk Mutation We have previously shown that the transient expression of MLPKf1 complemented the mlpk/mlpk mutation and restored the SI phenotype in mutated papilla cells (Murase et al., 2004). To test whether the MLPKf2 isoform also complements the mlpk/mlpk mutation, we adapted the transient assay. MLPKf2 and red fluorescent protein (RFP) genes were cointroduced into the papilla cells of mlpk/mlpk plants (S8S8mm) by particle bombardment. After confirming gene introduction by RFP fluorescence, self- or cross-pollen (S8S8 or S9S9) was attached to the RFP-expressing papilla cells and we monitored pollen tube growth microscopically. In control experiments in which only the RFP gene was introduced, 71% of self-pollen grains germinated and penetrated into papilla cells (Table 1). When RFP and MLPKf1 genes were cointroduced, the percentage of penetrated self-pollen tubes was significantly reduced (to 38%), confirming our previous results (Murase et al., 2004). When the MLPKf2 gene was cointroduced, the penetration of self-pollen tubes was also inhibited (to 36%), similar to MLPKf1. This inhibition was specific for self-pollen but not cross-pollen, suggesting the restoration of the SI phenotype of mlpk/mlpk plants. These results suggest that both MLPK isoforms can independently transduce SI signaling in papilla cells.
Membrane Localization Is Essential for MLPK Isoforms to Function in SI Signaling Both MLPK isoforms seemed to localize to the plasma membrane, although the localization mechanisms differed. This suggests that MLPK may function in the vicinity of SRK and that the plasma membrane localization is important for MLPK to function in SI signaling. To address this issue, we transiently expressed mutated forms of MLPK lacking membrane localization signals in papilla cells and monitored the complementation of the mlpk/mlpk mutation (Table 1). The MLPKf1G2A mutant form lacking the myristoylation site failed to complement the mlpk/mlpk mutation and failed to restore the SI phenotype. The MLPKf2ΔHR mutant form, which lacks the N-terminal hydrophobic region and loses its plasma membrane localization (Figure 4 MLPK Isoforms Directly Interact with SRK in the Plasma Membrane The prerequisite for plasma membrane localization of MLPK isoforms during SI signaling supported the view that MLPKs functions in the vicinity of SRK. To examine the possibility that MLPKs directly interact with SRK on the plasma membrane in plant cells, we used a BiFC assay (Hu et al., 2002). MLPKf1 and MLPKf2 were fused to N-terminal yellow fluorescent protein (YN), and SRK was fused to C-terminal yellow fluorescent protein (YC), and the fusion proteins were used for BiFC assays (Figure 5A
DISCUSSION Here, we describe an alternative MLPK isoform, MLPKf2, which is transcribed from an alternative transcription start site located in the third intron of the MLPKf1 gene. The resulting MLPKf2 isoform encodes a protein sequence identical to the MLPKf1 isoform, excepting the N terminus. Such expression systems, called alternative first exons (AFEs), in which the first exon of one splice variant of a gene is located within an intronic region of another variant, have been well documented in mammals and are suggested to contribute to the diversification of gene expression (Suzuki et al., 2001; Zavolan et al., 2002). Although some AFEs merely change the 5′-untranslated region and lead to no protein differences, many AFEs alter the N termini of the translated proteins, as is the case with MLPK. A very similar example of AFE was reported in c-Abl, a mammalian cytoplasmic Tyr kinase that is closely related to Src family kinases (Hantschel et al., 2003). Like MLPK, c-Abl is expressed by AFE in two isoforms, 1a and 1b, which differ only at the N termini. The 1b form contains a myristoylation signal and is expressed in divergent tissues, and the 1a form contains hydrophobic residues that are absent in 1b and is expressed in some tissues in a more specific manner (Renshaw et al., 1988; Nagar et al., 2003). When expressed under β-actin promoter, both isoforms could independently rescue most defects caused by c-Abl gene knockout (Hardin et al., 1996); thus, the functional difference of two isoforms and the biological significance of AFE remain unknown. Very few studies have looked at AFE transcripts in plants. Arabidopsis SYN1, a RAD21-like gene essential for meiosis, is one of the few reported AFE transcripts (Bai et al., 1999). Alternative promoters and splicing produced two SYN1 transcripts encoding similar-sized proteins differing only at their N termini. One transcript (BP2) was expressed at low levels in most tissues, whereas the other (BP5) was expressed only in prebolting buds. The low levels of BP2 expression throughout the plant suggested a potential role in processes other than meiosis, but its physiological significance remains unknown. Another example of AFE transcripts reported in plants is the SBE gene, which encodes a starch-branching enzyme (Hamada et al., 2002; Kitagawa et al., 2005). One shorter SBE transcript was expressed constitutively, while a longer transcript was expressed in limited tissues, including developing seeds. It was suggested that the differences between the N termini of SBE affect its enzymatic properties and subcellular localization. Thus, AFEs may play a role in the coupling of promoter selection (tissue-specific expression) and protein diversity (Kitagawa et al., 2005). In MLPK AFE transcripts, MLPKf1 is expressed divergently and weakly in most tissues, while MLPKf2 is predominantly expressed in stigma. This AFE system and the expression pattern of each transcript are conserved in APK1b, the Arabidopsis MLPK ortholog. This finding implies that the expression system has been conserved for more than 23 million years, since the genera Arabidopsis diverged from Brassica (Koch et al., 2000), suggesting a potential physiological implication for this expression system. Arabidopsis is a selfing plant that has lost functional SP11 and SRK alleles, but the transformation experiments of these genes suggested that the rest of the genes required to express the pollen rejection response remain intact (Nasrallah et al., 2002; Shimizu et al., 2004). MLPKf2 and APK1bf2, the major isoforms expressed in the stigma, must be the primary signal transducers functioning (or previously functioning) in SI signal transduction. By contrast, MLPKf1 and APK1bf1 isoforms are expressed in most tissues, including the stigma. Because MLPKf1 can complement the mlpk/mlpk mutation, it must also function in SI signal transduction in the stigma. However, the divergent expression profiles of these isoforms and the fact that a functional APK1b gene has been retained in Arabidopsis since the plant lost functional SP11 and SRK genes suggest the possibility that these isoforms play different roles in other tissues. To test for biological functions of APK1b aside from SI signal transduction, we analyzed a T-DNA knockout line for APK1b; we failed, however, to detect any phenotypic alterations including fertility (see Supplemental Figure 1 online). APK1b belongs to the subfamily RLCK VII, which comprises 46 members in Arabidopsis (Shiu and Bleecker, 2001), and some of these members are closely related to APK1b. For example, APK1a and NAK have 85 and 68% amino acid similarity with APK1bf1, respectively, and both of these genes are suggested to be divergently expressed in most tissues (http://www.cbs.umn.edu/Arabidopsis/; Figure 2A The plasma membrane localization of both GFP fusion proteins of MLPKf1 and MLPKf2 is consistent with the previous observation that native MLPK protein in stigma separated into the plasma membrane fraction during differential centrifugation and aqueous two-phase partitioning experiments (Murase et al., 2004). Interestingly, the two MLPK isoforms are targeted to the plasma membrane by different mechanisms. The membrane localization of MLPKf1 is myristoylation dependent, but that of MLPKf2 is dependent upon its specific N-terminal hydrophobic region. MLPKf1 has a typical plant myristoylation motif at its N terminus and incorporated myristic acid in an in vitro translation experiment. Proteins singly modified by N-myristoylation tend to be only loosely coupled to membranes, and in many cases, membrane association was further strengthened by the subsequent palmitoylation that often occurs at Cys residues near the N terminus (Thompson and Okuyama, 2000). The fourth Cys residue of MLPKf1 is highly conserved among the members of the RLCK VII subfamily (e.g., APK1bf1, APK1a, APK2a, and NAK; Figure 3B Myristoylation is an irreversible posttranslational protein modification found in animals, plants, fungi, and viruses. Despite the fact that a vast number of plant proteins contain consensus signature sequences for myristoylation and could theoretically be myristoylated (Podell and Gribskov, 2004), our knowledge is very limited as to whether they are in fact myristoylated and whether such a modification is important for their function. Calcium-dependent protein kinases (CDPKs) form a multigene family and are involved in various signaling pathways in plants (Raices et al., 2003; Gargantini et al., 2006). CDPKs exhibit a variety of subcellular localizations, and myristoylation was shown to be a prerequisite for the membrane localization of certain CDPK members, but the biological significance of such localization remains unclear. Myristoylation was shown to be essential for the function of a Ca2+ sensor protein, SOS3 (for salt overly sensitive 3), in plant salt tolerance (Ishitani et al., 2000). Why myristoylation is necessary for SOS3 function, however, remains a mystery, as no significant difference was observed between the membrane association of wild-type SOS3 and a nonmyristoylated SOS3 mutant. The tomato (Solanum lycopersicum) R gene product Pto confers race-specific resistance to Pseudomonas syringae pv tomato bacteria carrying avrPto or avrPtoB, and myristoylation was shown to be required for the induction of defense responses, including the hypersensitive responses (Andriotis and Rathjen, 2006; de Vries et al., 2006). The N-myristoylation of Pto did not affect its subcellular localization; rather, the N-myristoyl moiety was suggested to be involved in the interactions with downstream signaling components and/or the autoinhibition of its kinase activity. In contrast with these examples, clear relationships were observed for MLPKf1 between N-myristoylation, plasma membrane localization, and the biological function of SI signaling. This observation suggested that the membrane localization of MLPK is essential for SI signal transduction. This hypothesis was further strengthened by the observations that functional MLPKf2 also localized to the plasma membrane via a different mechanism using its specific hydrophobic amino acid region and that the deletion of this region resulted in both the loss of plasma membrane localization and the loss of biological function. The prerequisite for plasma membrane localization of MLPK during SI signaling could be explained by our BiFC assays, suggesting that MLPK directly interacts with SRK on the plasma membrane. In our previous study using a conventional yeast two-hybrid system and a split-ubiquitin membrane-based yeast two-hybrid system, we failed to detect a direct interaction between SRK and MLPK (Kakita et al., 2007). We showed that the recombinant SRK kinase domain could efficiently phosphorylate recombinant MLPK in vitro, suggesting that the interaction between SRK and MLPK should be rather weak or transient, as observed for certain interactions between mammalian kinases and their substrates (Miyazawa et al., 2002; Waas and Dalby, 2002). Thus, in this study, we used a BiFC assay system to detect a possible SRK-MLPK interaction because this system is known to stabilize weak or transient interactions (Bhat et al., 2006). The BiFC assays clearly suggested that both MLPKf1 and MLPKf2 specifically interact with SRK on the plasma membrane in plant protoplasts. The interaction was observed in the absence of SP11, as in the case of a previous interaction analysis between Brassinosteroid Insensitive1 (BRI1) and BRI1-associated receptor kinase using fluorescence life time imaging microscopy (Russinova et al., 2004). These results suggested that SRK and MLPK spontaneously interact on the stigmatic papilla cell membrane. Because the mlpk/mlpk mutants exhibit a complete self-compatible phenotype, MLPK must be a primary component of SI signaling. Only one other molecule that is suggested to function in the SI signaling pathway is a U-box motif-containing protein, ARC1 (Stone et al., 1999). ARC1 interacts directly with the kinase domain of SRK in a phosphorylation-dependent manner via a C-terminal arm repeat domain. ARC1 has U-box–dependent E3 ubiquitin ligase activity and is thought to be involved in the degradation of unknown compatibility factors in the pistil, leading in turn to pollen rejection (Stone et al., 2003). If ARC1 is also a primary component of SRK signaling, the SRK signal transferred to MLPK must return to SRK because ARC1 is a direct downstream effector of SRK. In animal cells, Src family kinases, which are myristoylated membrane-anchored Tyr kinases, are known to interact with activated receptor Tyr kinases and mutually stimulate the other's activity, thereby strengthening and prolonging the signal (Thomas and Brugge, 1997). MLPK acting as a coreceptor within the SRK receptor complex should be an attractive model for future studies of SI signaling. METHODS Plant Materials Self-incompatible Brassica rapa S8 and S9 homozygotes and the self-compatible mlpk/mlpk mutant line (S8S8mm) have been described previously (Murase et al., 2004). Tobacco (Nicotiana tabacum) BY-2 culture cells were maintained according to established procedures (Tse et al., 2006). RT-PCR and RACE Total RNA was isolated from various tissues using ISOGEN (Nippon Gene) according to the manufacturer's protocol. First-strand cDNA (cDNA) was synthesized from 1 μg of DNase I–treated total RNA using Superscript II RNaseH reverse transcriptase (Invitrogen). Target genes were amplified using the following primers: MLPKf1, MF1F (5′-ATGGGGATTTGCATGAGTGT-3′) and Race6 (5′-TTCATCCTCTAAGCAGTAACCGAT-3′); MLPKf2, MF2F (5′-ATGGGTTTTGTGAAAAAAGTG-3′) and Race6; ubiquitin (control) gene, Ubif (5′-ATGCAGATCTTTTGTGAAGAC-3′) and Ubir (5′-ACCACCACGGAAGACGGAG-3′). RT-PCR was conducted using the following profiles: 5 min denaturation at 94°C, followed by 28 cycles for MLPKf1, 25 cycles for MLPKf2, and 21 cycles for ubiquitin of 94°C for 30 s, 55°C for 30 s, and 68°C for 1 min. A final incubation was for 5 min at 72°C. After the PCR products were separated on 1% agarose gels and stained with ethidium bromide, gel images were captured using a UV illuminator. The 5′ RACE was performed using a GeneRacer kit (Invitrogen). First and nested PCR were performed with the MLPK gene-specific reverse primer M5race1 (5′-TGTCTAGTCTGAAATTCCTA-3′) and M5race3 (5′-TTGCAAGATCTCTCCTTCGG-3′), respectively. The PCR products were cloned into pGEM T-Easy (Promega) and sequenced. cDNA Screening A stigma cDNA library from an S36 homozygote was constructed in lambda ZapII (Stratagene), and a stigma cDNA library from an S9 homozygote was constructed in pBluescript II SK+ (Stratagene) using a cDNA synthesis kit (TaKaRa). A stigma full-length cDNA library of the S9 homozygote was constructed by Hitachi High-Technologies using the vector-capping method (Kato et al., 2005). An alkaliphosphatase-labeled MLPK cDNA probe was prepared using Alkphos Direct (GE Healthcare), and the stigma cDNA libraries were screened by plaque or colony hybridization. Two, one, and seven positive clones were obtained from 100,000 clones of the S36 stigma cDNA library, 40,000 clones of the S9 stigma cDNA library, and 200,000 clones of the S9 stigma full-length cDNA library, respectively. Real-Time RT-PCR Total RNA samples from B. rapa tissues were purified using ISOGEN (Nippongene) according to the manufacturer's protocols and treated with RNase-free DNaseI (Qiagen). The concentration and purity of total plant RNA was determined by spectrophotometric analysis. Expression profiles of MLPKf1 and MLPKf2 were analyzed by one-step real-time RT-PCR analyses using the QuantiTect SYBR Green RT-PCR kit (Qiagen) according to the manufacturer's protocol. All reactions contained 100 ng of total RNA, 1× QuantiTect SYBR Green RT-PCR Master Mix, 1 μM forward primer, 1 μM reverse primer, and 0.2 μL QuantiTect RT mix in a 20 μL total volume. The MLPKf1-specific forward primer was 5′-ATGGGGATTTGCATGAGTGTTC-3′, and the MLPKf2-specific forward primer was 5′-ATGGGTTTTGTGAAAAAAGTGCA-3′. The common reverse primer was 5′-GCTTGTTCTGACAGACACAGAAGAG-3′. The reaction was monitored using an ABI PRISM 7700 sequence detection system (Applied Biosystems). Reaction mixtures were incubated for 30 min at 50°C for reverse transcription and 15 min at 95°C, followed by 40 amplification cycles of 15 s at 94°C/30 s at 55°C/30 s at 60°C. To estimate absolute mRNA levels of unknown samples, a standard curve of a six-dilution series (1 × 103, 1 × 102, 1 × 10, 1 × 10°, 1 × 10−1, and 1 × 10−2 fg) was constructed from plasmid DNA quantified by a spectrophotometer. In Situ Hybridization The pistils of B. rapa S8S8 homozygote were collected 1 d before anthesis. The digoxigenin-labeled antisense and sense oligo-DNA probes were purchased from Nihon Gene Research Laboratory. The cDNA sequences used for antisense and sense probes were as follows: 5′-GATCCGTCTCAAAATCATGGGGATTTGCATGAGTGTTCAGGTTAAAGCTGAGAGTCCAAG-3′ for MLPKf1 and 5′-ACATTTGTCTGATCTCTTAATTACAACAAAACCATTTGTACTAAATTTCGGATAAATGGG-3′ for MLPKf2. In situ hybridization to 10-μm-thick Paraplast (Sigma-Aldrich) sections of formaldehyde-fixed pistils was performed as previously described (Shiba et al., 2002). In Vitro Myristoylation Assay For in vitro transcription and translation analyses, the pCMVTnT vector (Promega) was converted to a Gateway-compatible destination vector (pCMVTnT/gw) using the Gateway vector conversion system (Invitrogen). The following forward primers were used for PCR amplification from the cDNA: MLPKf1, 5′-CACCATGGGATTTGCATGAGTGTTCAG-3′; MLPKf2, 5′-CACCATGGGTTTTGTGAAAAAAGTGCAATC-3′; MLPKf1G2A, 5′-CACCATGGCGATTTGCATGAGTGTTCAGGTTAAAG-3′; and MLPKf2G2A, 5′-CACCATGGGTTTTGTGAAAAAAGTGCAATCAAAAGGTGCGAGTCCGA-3′. The common reverse primer was 5′-TCAGACAAACAGAGGCGAAGCAGACGGAC-3′. The amplified fragments were cloned into the pENTR/D-TOPO cloning vector (Invitrogen) and recombined into pCMVTnT/gw using Gateway LR clonase mix (Invitrogen). In vitro transcription and translation reactions were performed using the TnT-coupled wheat germ extract system (Promega). MLPKf1, MLPKf2, MLPKf1G2A, and MLPKf2G2A were transcribed and translated in TNT quick master mix containing wheat germ extract (Promega) at 30°C for 120 min. Radiolabeling was performed with 5 μCi l-[35S] Met (1000 Ci/mM; GE Healthcare) in the presence of 20 μM amino acids (minus Met) or 50 μCi [9, 10 (n)-3H] myristic acid (54 Ci/mM; GE Healthcare). Aliquots of reaction products were separated by SDS-PAGE, gels were dried, and autoradiograms were captured by a BAS2500 IP Reader (Fujifilm). Transient Expression of the MLPK-GFP Fusion Protein The previously described plasmid 35S:GFP/pBI221 (Murase et al., 2004) was converted to a Gateway-compatible destination vector (pGFP/gw) using the Gateway vector conversion system. The entry vectors for the expression of MLPKf1, MLPKf2, MLPKf1G2A, and MLPKf2G2A were prepared by PCR using the same forward primers used in the in vitro transcription/translation analyses. For the expression of MLPKf2ΔHR, the following forward primer was used: 5′-CACCATGGGTTTTGTGAAAAAAGTGCAATCAAAAGGTGCGAGTCCGAAGTATATG-3′. The common reverse primer was 5′-GACAAACAGAGGCGAAGCAGACGG-3′. Full-length S9-SRK (D88193) was amplified from stigmatic cDNA of B. rapa S9 homozygote using the specific primers 5′-CACCATGAAAGGTGTACGAAACAT-3′ and 5′-GCGGGCATCTATGACTGAGCAGGT-3′. The full-length RLK-1 (At1g09970) and RLK-2 (At5g25930) were amplified from Arabidopsis thaliana stigmatic cDNA using the following primer pairs: RLK-1, 5′-CACCATGGCTCCGTCGTTAAGGAATTTCA-3′ and 5′-ACTTATTTCTTTGACCTTGACATCACT-3′; and RLK-2, 5′-CACCATGACTCGTTTACCCTTACCTTTC-3′ and 5′-TACAAAACCTAAATCTTCATCTTCTAC-3′. All amplified fragments were cloned into the pENTR/D-TOPO cloning vector and then recombined into pGFP/gw. Tobacco BY-2 culture cells were incubated in an enzyme solution (1% [w/v] of cellulase Onozuka RS [Yakult], 0.1% [w/v] pectolyase Y-23 [Kikkoman], 0.4 M mannitol, and 5 mM MES-KOH, pH 5.8) for 2 h at room temperature. BY-2 protoplasts were collected by centrifugation (5 min at 100g) and washed twice in wash buffer (0.4 M mannitol, 70 mM CaCl2, and 5 mM MES-KOH, pH 5.8). Polyethyleneglycol-mediated transient transformation of protoplasts was performed as described (Abel and Theologis, 1994). GFP-expressing cells were analyzed by fluorescence confocal microscopy. Complementation Experiments The RFP expression vector, pSLG-RFP, has been previously described (Murase et al., 2004). For the expression of MLPK-related genes, the pSLG9 plasmid containing the 3.2-kb 5′-upstream region of the SLG9 gene (Murase et al., 2004) was converted to a Gateway-compatible destination vector (pSLG/gw) using the Gateway vector conversion system. The MLPKf1, MLPKf2, MLPKf1G2A, and MLPKf2ΔHR genes were amplified by PCR using the above-described forward primers and the common reverse primer 5′-TCAGACAAACAGAGGCGAAGCAGACGGAC-3′. All fragments were cloned into the pENTR/D-TOPO cloning vector and then recombined into pSLG/gw. The procedure of transiently expressing the RFP and MLPK-related genes in mlpk/mlpk papilla cells was performed as described previously (Murase et al., 2004). Pistils were collected from B. rapa (S8S8mm) flower buds 1 d prior to flowering and placed onto Murashige and Skoog nutrient agar medium containing Gamborg B5 vitamins and 3% sucrose. Stigmas were bombarded twice with 100 μg of gold particles (1 μm diameter) coated with 2 μg of each plasmid using the PDS-1000/He system (Bio-Rad) fitted with 900-p.s.i. rupture discs. After incubating 18 h at 22°C, self (S8S8)- or cross (S9S9)-pollen grains were attached onto RFP-expressing papilla cells using a micromanipulator. After 2 h, the pollen grains were examined microscopically for pollen tube penetration into papilla cells. BiFC Assay A hemagglutinin (HA) epitope tag fragment from pGADT7 (Clontech) was inserted into the EcoRV site of pCMV-script (Invitrogen) and designated pCMV-HA. The sequences encoding the N-terminal fragment comprised of residues 1 to 154 (YN), as well as the C-terminal fragment comprised of residues 155 to 238 (YC) of the Venus YFP valiant (Nagai et al., 2002; Shyu et al., 2006), were amplified using the following primer pairs: YN, 5′-AATAAAGCTTATGGTGAGCAAGGGGCGAGGA-3′ and 5′-TATTCTCGAGTTAGGTGATATAGACGTTGTGGC-3′; and YC, 5′-AATTAAGCTTGCCGACAAGCAGAAGAACGG-3′ and 5′-AATTCTCGAGTTACTTGTACAGCTCGTCCA-3′. The amplified YN and YC sequences were integrated into the HindIII/XhoI site of pCMV-HA. The obtained fusion sequences, HA-VN and HA-VC, were inserted into the BamHI/SacI site of pBI221 vector and converted to the Gateway-compatible destination vectors (pVN/gw and pVC/gw, respectively) using the Gateway conversion system. The MLPKf1, MLPKf2, MLPKf1G2A, and MLPKf2ΔHR entry vectors were recombined into pVN/gw using Gateway LR clonase mix. SRK, RLK1, and RLK2 entry vectors were recombined into pVC/gw. The plasmid DNA containing eCFP, eCFP/pRSETB, was provided by A. Miyawaki (Shimozono et al., 2006). The eCFP fragment, excised from eCFP/pRSETB using BamHI and HindIII, was inserted into the BamHI/SacI site of pBI221 vector and used as a transformation marker. Transient transformation of BY-2 protoplasts was performed as described above. Twelve hours after transformation, the protoplasts were treated with or without S9-SP11 (10 nM), and the fluorescence was monitored by a spectral imaging fluorescence microscope system (LSM510 META; Carl Zeiss). Accession Numbers Supplemental Data The following material is available in the online version of this article.
[Supplemental Data]
Acknowledgments We thank Atsushi Miyawaki (RIKEN, Saitama, Japan) for providing the vectors of the GFP variants, Ko Kato (Nara Institute of Science and Technology) for providing the tobacco BY-2 cells, Tetsuyuki Entani (Nara Institute of Science and Technology) for helpful discussions, and Hitomi Ichikawa, Satsuki Takahashi, Aya Ota, Mami Ohue, Maki Matsumura, Yoshie Ohnishi, and Humiyo Yamamoto for their technical assistance. This work was supported by Grants-in-Aid for Creative Scientific Research (16GS0316 to A.I.), by Grants-in-Aid for Scientific Research (16380072, 18380069, and 18075008 to S.T), and by the global Centers of Excellence Program to Nara Institute of Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Notes The author responsible for distribution of materials integral to the findings presented in this article in accordance with the policy described in the Instructions for Authors (www.plantcell.org) is: Seiji Takayama (takayama/at/bs.naist.jp). [W]Online version contains Web-only data. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Annu Rev Plant Biol. 2005; 56():467-89.
[Annu Rev Plant Biol. 2005]Proc Natl Acad Sci U S A. 1991 Oct 1; 88(19):8816-20.
[Proc Natl Acad Sci U S A. 1991]Science. 1999 Nov 26; 286(5445):1697-700.
[Science. 1999]Genetics. 1999 Sep; 153(1):391-400.
[Genetics. 1999]Nature. 2000 Feb 24; 403(6772):913-6.
[Nature. 2000]Proc Natl Acad Sci U S A. 2000 Feb 15; 97(4):1920-5.
[Proc Natl Acad Sci U S A. 2000]Plant Cell. 2003 Apr; 15(4):885-98.
[Plant Cell. 2003]Proc Natl Acad Sci U S A. 1998 Jan 6; 95(1):382-7.
[Proc Natl Acad Sci U S A. 1998]Science. 1999 Nov 26; 286(5445):1729-31.
[Science. 1999]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Proc Natl Acad Sci U S A. 2001 Sep 11; 98(19):10763-8.
[Proc Natl Acad Sci U S A. 2001]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Plant Mol Biol. 1992 Nov; 20(4):653-62.
[Plant Mol Biol. 1992]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Methods Enzymol. 1991; 200():38-62.
[Methods Enzymol. 1991]J Biol Chem. 2003 Oct 31; 278(44):43418-29.
[J Biol Chem. 2003]Proc Natl Acad Sci U S A. 1981 Jun; 78(6):3824-8.
[Proc Natl Acad Sci U S A. 1981]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Mol Cell. 2002 Apr; 9(4):789-98.
[Mol Cell. 2002]EMBO Rep. 2001 May; 2(5):388-93.
[EMBO Rep. 2001]Genome Res. 2002 Sep; 12(9):1377-85.
[Genome Res. 2002]Cell. 2003 Mar 21; 112(6):845-57.
[Cell. 2003]Mol Cell Biol. 1988 Oct; 8(10):4547-51.
[Mol Cell Biol. 1988]Cell. 2003 Mar 21; 112(6):859-71.
[Cell. 2003]Plant Cell. 1999 Mar; 11(3):417-30.
[Plant Cell. 1999]J Biol Chem. 2002 May 10; 277(19):16538-46.
[J Biol Chem. 2002]Bioinformatics. 2005 May 1; 21(9):1758-63.
[Bioinformatics. 2005]Mol Biol Evol. 2000 Oct; 17(10):1483-98.
[Mol Biol Evol. 2000]Science. 2002 Jul 12; 297(5579):247-9.
[Science. 2002]Science. 2004 Dec 17; 306(5704):2081-4.
[Science. 2004]Proc Natl Acad Sci U S A. 2001 Sep 11; 98(19):10763-8.
[Proc Natl Acad Sci U S A. 2001]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Prog Lipid Res. 2000 Jan; 39(1):19-39.
[Prog Lipid Res. 2000]BMC Genomics. 2004 Jun 17; 5(1):37.
[BMC Genomics. 2004]Plant Mol Biol. 2003 Jul; 52(5):1011-24.
[Plant Mol Biol. 2003]Plant J. 2006 Dec; 48(6):843-56.
[Plant J. 2006]Plant Cell. 2000 Sep; 12(9):1667-78.
[Plant Cell. 2000]J Biol Chem. 2006 Sep 8; 281(36):26578-86.
[J Biol Chem. 2006]Genes Cells. 2002 Dec; 7(12):1191-204.
[Genes Cells. 2002]J Biol Chem. 2002 Apr 12; 277(15):12532-40.
[J Biol Chem. 2002]Plant Methods. 2006 Jun 26; 2():12.
[Plant Methods. 2006]Plant Cell. 2004 Dec; 16(12):3216-29.
[Plant Cell. 2004]Science. 1999 Nov 26; 286(5445):1729-31.
[Science. 1999]Plant Cell. 2003 Apr; 15(4):885-98.
[Plant Cell. 2003]Annu Rev Cell Dev Biol. 1997; 13():513-609.
[Annu Rev Cell Dev Biol. 1997]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Plant Physiol. 2006 Dec; 142(4):1442-59.
[Plant Physiol. 2006]DNA Res. 2005 Feb 28; 12(1):53-62.
[DNA Res. 2005]Plant Cell. 2002 Feb; 14(2):491-504.
[Plant Cell. 2002]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Plant J. 1994 Mar; 5(3):421-7.
[Plant J. 1994]Science. 2004 Mar 5; 303(5663):1516-9.
[Science. 2004]Nat Biotechnol. 2002 Jan; 20(1):87-90.
[Nat Biotechnol. 2002]Biotechniques. 2006 Jan; 40(1):61-6.
[Biotechniques. 2006]Biochemistry. 2006 May 23; 45(20):6267-71.
[Biochemistry. 2006]